no image available Dickens & Co. "Eyes on the Horizon: Bevacizumab's Breakthrough in Conjunctival Cancer Prevention" "Revolutionizing the Treatment of Conjunctival Intraepithelial Neoplasia with Targeted Therapy" Price: 26.00€